SynthesisBriefings in bioinformatics2026
A systematic review of molecular representation learning foundation models.
Synthesis in Briefings in bioinformatics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- BONAFIDE: a Python framework for the calculation of local features for atoms and bonds in molecules.Journal of cheminformatics · 2026Article
- Graph-based drug-target interaction modeling: from representation learning to output-driven drug discovery.Briefings in bioinformatics · 2026Review
- Machine-Learning-Driven Molecular Design and Structure-Property-Performance Relationships in Pharmaceutical Chemistry.Molecules (Basel, Switzerland) · 2026Review
- GNN-MA: Soft Molecular Alignment with Cross-Graph Attention for Ligand-Based Virtual Screening.Molecules (Basel, Switzerland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Molecular representation learning (MRL) is afoundation in leveraging computational methods for drug discovery, enabling the transformation of molecular structure and properties into numerical vectors. These vectors serve as input for machine learning models and facilitate the prediction and analysis of molecular attributes, functions, and reactions. The advent of foundation models has introduced both new opportunities and challenges to MRL. These models have improved generalizability and migration in scarce data. Through pretraining and fine-tuning, foundation models can be adapted to various domains. Their robust encoding and generative abilities also allow the transformation of molecular data into more expressive forms. This paper provides a detailed review of current mainstream molecular descriptors and datasets, focusing primarily on the representation of small molecules while excluding larger molecules such as proteins and peptides. It classifies foundation models into two primary categories based on the form of input: unimodal-based and multimodal-based models. For each category, representative models are identified and their advantages and disadvantages evaluated. Moreover, we systematically summarize four core pretraining strategies for MRL foundation models, analyzing their task designs, applicable scenarios, and impacts on downstream performance. In addition, the application of molecular representation foundation models in drug discovery and development is discussed, together with the current status of model interpretability. The paper concludes with insights into the future directions of MRL foundation models.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.